Cited by 482Liver physiology and pathologyLiver Disease and TransplantationLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Liver sinusoidal endothelial cells in hepatic fibrosis

Open access

DeLeve, Laurie D.·2015·Hepatology

Open this paper in CoChat — free account

Abstract

Capillarization, lack of liver sinusoidal endothelial cell (LSEC) fenestration, and formation of an organized basement membrane not only precedes fibrosis, but is also permissive for hepatic stellate cell activation and fibrosis. Thus, dysregulation of the LSEC phenotype is a critical step in the fibrotic process. Both a vascular endothelial growth factor (VEGF)‐stimulated, nitric oxide (NO)‐independent pathway and a VEGF‐stimulated NO‐dependent pathway are necessary to maintain the differentiated LSEC phenotype. The NO‐dependent pathway is impaired in capillarization and activation of this pathway downstream from NO restores LSEC differentiation in vivo . Restoration of LSEC differentiation in vivo promotes HSC quiescence, enhances regression of fibrosis, and prevents progression of cirrhosis. (H epatology 2015;61:1740–1746)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.27376

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805 · cited 1×
“In vivo studies have suggested that activated HSCs do not revert to full quiescence upon regression of fibrosis, but that HSCs that develop a quiescent phenotype after regression of fibrosis are poised to rapidly reactivate when challenged with a fibrotic stimulus.(47) These HSCs have been termed inactivated HSCs.”
Background
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758 · cited 1×
“In normal liver, LSECs are tolerogenic (44, 45).”
Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613 · cited 1×
“During chronic liver disease, Kupffer cells prevent HSC apoptosis and thereby sustain the fibrotic process.(51) Thus, there is an intricate interplay among the nonparenchymal cells that either prevents or sustains HSC activation and thereby determines fibrosis (Fig.”
Capillarization of hepatic sinusoids in man
Schaffner, F., & Popper, H. (1963) · Gastroenterology · doi:10.1016/s0016-5085(63)80130-4 · Cited by 610 · cited 1×
“INTRODUCTION Capillarization, which is when liver sinusoidal endothelial cells (LSECs) lack fenestration and develop an organized basement membrane (1), is a prelude to fibrosis.”
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis
Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R. Y., Housset, C., & Rosmorduc, O. (2002) · Hepatology · doi:10.1053/jhep.2002.32524 · Cited by 483 · cited 1×
“VEGF is upregulated in cirrhosis (33, 34), so that total VEGF is not rate limiting in this process.”
Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis.
Jarnagin, W. R., Rockey, D. C., Koteliansky, V., Wang, S. S., & Bissell, D. M. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.2037 · Cited by 452 · cited 2×
“LSECs in a bile duct ligation model make increased quantities of EIIIAfibronectin.(42) HSCs cultured on matrix conditioned by LSECs isolated from the bile duct ligation model show increased activation that is blocked by antibodies to EIIIA fibronectin.”
Background
LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.
Carreira, C. M., Nasser, S. M., di Tomaso, E., Padera, T. P., Boucher, Y., Tomarev, S. I., & Jain, R. K. (2001) · PubMed · Cited by 444
Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069036.63405.5c · Cited by 417 · cited 1×
“During resolution of fibrosis, the decline in activated HSC is due to both reversion to quiescence and apoptosis (28, 50).”
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Xie, G., Wang, X., Wang, L., Wang, L., Atkinson, R. D., Kanel, G. C., Gaarde, W. A., & DeLeve, L. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.017 · Cited by 410
Self-citation
Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
DeLeve, L. D., Wang, X., & Guo, Y. (2008) · Hepatology · doi:10.1002/hep.22351 · Cited by 408 · cited 5×
“Hepatocytes are unable to maintain HSC quiescence unless the culture medium is supplemented with an NO-donor, but it remains to be determined whether NO contributes to the paracrine effect of LSECs on HSC quiescence or whether other paracrine factors are necessary.(36) Our group and others have reported that NO produc…”
BackgroundMethodInfluentialSelf-citation

Flagged first, then by citations

Show all 50 references

Sorted by citations

Items 201–300 of 480

Extracellular vesicles derived from liver sinusoidal endothelial cells inhibit the activation of hepatic stellate cells and Kupffer cells in vitro
Wang, J., Wu, Z., Xia, M., Salas, S. S., Arroyave-Ospina, J. C., Buist‐Homan, M., Harmsen, M. C., & Moshage, H. J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167020 · Cited by 25
The Involving Roles of Intrahepatic and Extrahepatic Stem/Progenitor Cells (SPCs) to Liver Regeneration
Liu, W., Ren, L., Wang, T., Navarro–Álvarez, N., & Tang, L. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15715 · Cited by 25
“Two populations of SEPCs have been identified: BM SEPCs and resident or intrahepatic SEPCs (Figure 4) [9, 10, 73].”
Background
Tetramethylpyrazine attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic angiogenesis in rats
Zhao, S., Zhang, Z., Qian, L., Lin, Q., Zhang, C., Shao, J., Zhang, F., & Zheng, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.122 · Cited by 24
Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis
Yuan, Y., Li, J., Chen, M., Zhao, Y., Zhang, B., Chen, X., Zhao, J., Liang, H., & Chen, Q. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.012 · Cited by 30
miRNA in Rat Liver Sinusoidal Endothelial Cells and Hepatocytes and Application to Circulating Biomarkers that Discern Pathogenesis of Liver Injuries
Oda, S., Takeuchi, M., Akai, S., Shirai, Y., Tsuneyama, K., & Yokoi, T. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.12.007 · Cited by 24
Exploring the transcriptomic network of multi-ligand scavenger receptor Stabilin-1- and Stabilin-2-deficient liver sinusoidal endothelial cells
Olsavszky, V., Sticht, C., Schmid, C. D., Winkler, M., Wohlfeil, S. A., Olsavszky, A., Schledzewski, K., Géraud, C., Goerdt, S., Leibing, T., et al. (2020) · Gene · doi:10.1016/j.gene.2020.145284 · Cited by 24
Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells
Zhang, D., Zhang, L., Chen, G., Xu, Y., Yang, H., Xiao, Z., Chen, J., Mu, Y., Zhang, H., Liu, W., et al. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1855212 · Cited by 23
Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway
Fu, C., Zhang, Y., Xi, W. J., Xu, K., Meng, F., Ma, T., Li, W., Wu, L., & Chen, Z. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116191 · Cited by 23
AMP-activated protein kinase activator, HL156A reduces thioacetamide-induced liver fibrosis in mice and inhibits the activation of cultured hepatic stellate cells and macrophages
Lee, H. S., Shin, H.-S., Choi, J. H., Bae, S., Wee, H., Son, T., Seo, J. H., Park, J., Kim, S., & Kim, K. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3627 · Cited by 23
Advances in the clinical use of collagen as biomarker of liver fibrosis
Meurer, S. K., Karsdal, M. A., & Weiskirchen, R. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1814746 · Cited by 22
Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review)
Cheng, Q.-N., Yang, X. Y., Wu, J., Ai, W., & Ni, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12003 · Cited by 22
Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions
Ezhilarasan, D., & Najimi, M. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30915 · Cited by 22
The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model
van Riet, S., Julien, A., Atanasov, A., Nordling, Å., & Ingelman‐Sundberg, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000374 · Cited by 22
“[28] The spheroids contained hepatocytes originating from either the perivenous or periportal liver region, and the cellular phenotypes persisted for long periods of cultivation (Figure 1B).”
Background
Hepatic stellate cells promote angiogenesis via the TGF-β1-Jagged1/VEGFA axis
Jin, X., Yasen, A., Chen, Z., Wang, W., & Li, D. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.07.045 · Cited by 22
Current therapies and novel approaches for biliary diseases
Rajapaksha, I. G., Angus, P., & Herath, C. B. (2019) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v10.i1.1 · Cited by 25
Advances in the understanding of the role and mechanism of action of PFKFB3‑mediated glycolysis in liver fibrosis (Review)
Liu, Q., Li, J., Li, X., Zhang, L., Yao, S., Wang, Y., Tuo, B., & Jin, H. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5429 · Cited by 24
“The inhibition of PFKFB3 was shown to quench proliferating endothelial cells to maintain phenotypic homeostasis (118).”
Background
Extracellular vesicles: catching the light of intercellular communication in fibrotic liver diseases
Li, Y., Wu, J., Liu, R., Zhang, Y., & Li, X. (2022) · Theranostics · doi:10.7150/thno.77256 · Cited by 21
“, myofibroblasts), becoming the core factor driving fibrosis [7-9].”
Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases
Han, D., Xu, K., Jin, Z., Xu, Y., Li, Y., Wang, L., Cao, Q., Kim, K.-P., Ryu, D. H., Hong, K., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85145 · Cited by 21
“Defenestration, the main characteristic of activated LSECs, precedes fibrogenesis in the liver (77).”
BMP-9 Modulates the Hepatic Responses to LPS
Gaitantzi, H., Karch, J., Germann, L., Cai, C., Rausch, V., Birgin, E., Rahbari, N. N., Seitz, T., Hellerbrand, C., König, C., et al. (2020) · Cells · doi:10.3390/cells9030617 · Cited by 21
“If LSEC become capillarized they lose their protective properties like phagocytosis and keeping HSC unactivated [18,34].”
The vascular endothelial growth factor signaling pathway regulates liver sinusoidal endothelial cells during liver regeneration after partial hepatectomy
Lu, J., Zhao, Y.-L., Zhang, X.-Q., & Li, L.-J. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1815532 · Cited by 22
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis
Hu, Y., Yang, B., Xiao, C., Yang, X., Zhang, H., Yang, P., Du, X., Zhang, G., Liang, B., Bai, N., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.001 · Cited by 25
Emerging Therapeutic Targets for Portal Hypertension
Felli, É., Nulan, Y., Selicean, S. E., Wang, C., Gracia‐Sancho, J., & Bosch, J. (2023) · Current Hepatology Reports · doi:10.1007/s11901-023-00598-4 · Cited by 22
Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH
Sakai, A., Takeda, K., & Takeuchi, M. (2023) · Antioxidants · doi:10.3390/antiox12030748 · Cited by 20
“Numerous studies, including extensive reviews, have confirmed the progression of NALFD through the stages of steatosis, ballooning, inflammation, fibrosis, cirrhosis, and HCC [1,6].”
Background
Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease
Li, Y., Yunrui, L. U., Mozuo, N. I. A. N., Sheng, Q., ZHANG, C., Han, C. Q., Dou, X., & Ding, Y. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60443-1 · Cited by 21
Pivotal roles of Kupffer cells in the progression and regression of DDC-induced chronic cholangiopathy
Jemail, L., Miyao, M., Kotani, H., Kawai, C., Minami, H., Abiru, H., & Tamaki, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-24825-x · Cited by 20
Liver sinusoidal endothelial cells in hepatic fibrosis: opportunities for future strategies
Chen, T., Zhang, H., Shan, W., Zhou, J., & You, Y. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151881 · Cited by 19
Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease
Hide, D., Gil, M., Andrade, F., Rafael, D. F. D. S., Raurell, I., Bravo, M., Barberá, A., Gracia‐Sancho, J., Vargas, V., Augustín, S., et al. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102267 · Cited by 19
Folate Decoration Supports the Targeting of Camptothecin Micelles against Activated Hepatic Stellate Cells and the Suppression of Fibrogenesis
Li, X., Wang, X., Shao, Y., Jiao, Q., Jiang, C., Zheng, X., Zhou, S., & Chen, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c16616 · Cited by 19
α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
Schwinghammer, U., Melkonyan, M. M., Hunanyan, L. S., Tremmel, R., Weiskirchen, R., Borkham‐Kamphorst, E., Schaeffeler, E., Seferyan, T., Mikulits, W., Yenkoyan, K. B., et al. (2020) · Cells · doi:10.3390/cells9020456 · Cited by 19
“Acknowledging the importance of liver sinusoidal endothelial cell fenestration in the maintenance of normal liver function and its decrease during fibrosis/cirrhosis [22], we investigated the role of α2-ARs in the permeability and differentiation of hLSECs [23].”
Background
Matrix sieving-enforced retrograde transcytosis regulates tissue accumulation of C-reactive protein
Li, H., Liu, X., Liu, Y.-T., Jia, Z.-K., Filep, J. G., Potempa, L. A., Ji, S., & Wu, Y. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy181 · Cited by 19
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management
Adinolfi, L. E., Marrone, A., Rinaldi, L., Nevola, R., Izzi, A., & Sasso, F. C. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001281 · Cited by 18
JAM‐A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence
Brozat, J. F., Brandt, E. F., Stark, M., Fischer, P., Wirtz, T. H., Flaßhove, A., Rodenhausen, A. N., Vajen, T., Heinzmann, A. C. A., Schmitz, S. M., et al. (2022) · Liver International · doi:10.1111/liv.15187 · Cited by 18
FAK-p38 signaling serves as a potential target for reverting matrix stiffness-modulated liver sinusoidal endothelial cell defenestration
Zhang, X., Li, P., Zhou, J., Zhang, Z., Wu, H., Shu, X., Li, W., Wu, Y. C., Lü, S., Lü, D., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2023.122462 · Cited by 22
Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction
Uschner, F. E., Glückert, K., Paternostro, R., Gnad, T., Schierwagen, R., Mandorfer, M., Magdaleno, F., Ortiz, C., Schwarzkopf, K. M., Kamath, P. S., et al. (2020) · Liver International · doi:10.1111/liv.14586 · Cited by 18
Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients
Osawa, Y., Yoshio, S., Aoki, Y., Korenaga, M., Imamura, M., Oide, T., Okawara, M., Kawai, H., Tsutsui, Y., Yoshida, Y., et al. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01633-8 · Cited by 18
Mechanotransduction of liver sinusoidal endothelial cells under varied mechanical stimuli
Shu, X., Li, N., Wu, Y. C., Li, W., Zhang, X., Li, P., Lü, D., Lü, S., & Long, M. (2021) · Acta Mechanica Sinica · doi:10.1007/s10409-021-01057-3 · Cited by 17
Plasticity of monocytes and macrophages in cirrhosis of the liver
Geng, A., Flint, E., & Bernsmeier, C. (2022) · Frontiers in Network Physiology · doi:10.3389/fnetp.2022.937739 · Cited by 18
“The liver sinusoidal endothelium is highly affected in cirrhosis due to its capillarization and angioarchitectural change (DeLeve, 2015; Su et al., 2021).”
Background
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms
Mitten, E. K., Portincasa, P., & Baffy, G. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00029 · Cited by 17
Hepatoprotective Effect of Medicine Food Homology Flower Saffron against CCl4-Induced Liver Fibrosis in Mice via the Akt/HIF-1α/VEGF Signaling Pathway
Jiang, H., Huang, X., Wang, J., Zhou, Y., Ren, C., Zhou, T., & Pei, J. (2023) · Molecules · doi:10.3390/molecules28217238 · Cited by 17
Extracellular Matrix Stiffness-Induced Mechanotransduction of Capillarized Liver Sinusoidal Endothelial Cells
Wu, Q., Sun, Q., Zhang, Q., Wang, N., Lv, W., & Han, D. C. (2024) · Pharmaceuticals · doi:10.3390/ph17050644 · Cited by 17
Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective
Baffy, G., & Portincasa, P. (2024) · Metabolites · doi:10.3390/metabo14060324 · Cited by 19
“…major liver cell types, including parenchymal hepatocytes, liver sinusoidal endothelial cells (LSECs), hepatic stellate cells (HSCs), and Kupffer cells, have been implicated in the development of subclinical portal hypertension via cellular dysfunction and a web of cell–cell interactions [18,19].”
Background
Early steatohepatitis in hyperlipidemic mice with endothelial-specific gain of TRPC3 function precedes changes in aortic atherosclerosis
Smedlund, K., Dube, P., & Vázquez, G. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00067.2016 · Cited by 17
“Apoptosis of LSECs can also lead to fibrosis (7).”
Stellate Cells and Hepatic Fibrosis
Hasegawa, D., Wallace, M. C., & Friedman, S. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00004-x · Cited by 17
Reversal of NASH fibrosis with pharmacotherapy
Alukal, J. J., & Thuluvath, P. J. (2019) · Hepatology International · doi:10.1007/s12072-019-09970-3 · Cited by 17
Effects of Salvia hispanica L. (chia) seed on blood coagulation, endothelial dysfunction and liver fibrosis in an experimental model of Metabolic Syndrome
Oliva, M. E., Ingaramo, P. I., Joubert, M. B. V., Ferreira, M. D. R., & D’Alessandro, M. E. (2021) · Food & Function · doi:10.1039/d1fo02274a · Cited by 17
Defenestration of Liver Sinusoidal Endothelial Cells: The Trigger of Liver Fibrosis
Zhou, J., Wang, J., Zhang, L., Zhang, C., & Tian, C. (2025) · Pharmaceuticals · doi:10.3390/ph18060893 · Cited by 18
Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities
Lin, A., Xiong, M., Tang, B., Jiang, A., Shen, J., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2025) · Hepatology International · doi:10.1007/s12072-025-10838-y · Cited by 17
Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice
Campreciós, G., Ruart, M., Anton, A., Suárez-Herrera, N., Montironi, C., Martínez–Sánchez, C., Jiménez, N., Lafoz, E., García‐Calderó, H., Vilaseca, M., et al. (2021) · Nutrients · doi:10.3390/nu13113700 · Cited by 16
“Supporting this notion, quantification of LSEC fenestrae by SEM, which is the “gold standard” to evaluate LSEC dedifferentiation [22,24], also displayed increased porosity and the number of fenestrae in SPD-treated livers (Figure 1D).”
Method
Association of Differentially Altered Liver Fibrosis with Deposition of TGFBi in Stabilin-Deficient Mice
Krzistetzko, J., Géraud, C., Dormann, C., Riedel, A., & Leibing, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310969 · Cited by 15
“Defenestration and capillarization of LSECs represent an important step in the progression of liver fibrosis and, ultimately, cirrhosis [23].”
Background
Effect of caffeine and other xanthines on liver sinusoidal endothelial cell ultrastructure
Mao, H., Szafranska, K., Kruse, L. D., Holte, C. F., Wolfson, D. L., Ahluwalia, B. S., Whitchurch, C. B., Cole, L., Lockwood, G. P., Diekmann, R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40227-0 · Cited by 16
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway
Park, A. Y., Leney-Greene, M. A., Lynberg, M., Gabrielski, J. Q., Xu, X., Schwarz, B. H., Zheng, L., Balasubramaniyam, A., Ham, H., Chao, B. N., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01691-y · Cited by 16
Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway
Ding, Q., Li, Z., Liu, B., Ling, L., Tian, X., & Zhang, C. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.02.018 · Cited by 16
Fate tracing of hepatocytes in mouse liver
Gu, X., Huang, D., Ci, L., Shi, J., Zhang, M., Yang, H., Wang, Z., Sheng, Z., Sun, R., & Fei, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-15973-7 · Cited by 16
Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification
Lee, A.-R., Nam, K., Lee, B. J., Lee, S.-W., Baek, S.-M., Bang, J.-S., Choi, S., Park, S., Kim, T., Jeong, K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153812 · Cited by 16
“LSECs form a permeable barrier, at the interface between the sinusoidal vessels and the space of Disse [28,29].”
Background
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
Li, Y., Zhu, B., Shi, K., Lu, Y., Zeng, X., Li, Y., Zhang, Q., Feng, Y., & Wang, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1515400 · Cited by 15
Sulodexide attenuates liver fibrosis in mice by restoration of differentiated liver sinusoidal endothelial cell
Huang, R., Deng, J., Zhu, C.-P., Liu, S., Cui, Y., Chen, F., Zhang, X., Tao, X., & Xie, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114396 · Cited by 15
Crosstalk in extrahepatic and hepatic system in NAFLD / NASH
Duan, Y., Yang, Y. Z., Zhao, S., Bai, Y., Yao, W., Gao, X., & Yin, J. (2024) · Liver International · doi:10.1111/liv.15967 · Cited by 16
“153 LSECs produce angiocrine signals that contribute to both liver regeneration and fibrosis after chronic injury (Figure 6 ).”
Splanchnic and systemic circulation cross talks: Implications for hemodynamic management of liver transplant recipients
Mukhtar, A. M., Lotfy, A., Hussein, A., & Fouad, E. A. (2019) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2019.12.003 · Cited by 15
Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis
Sun, X., Tan, Y., Lyu, J., Liu, H., Zhao, Z., & Liu, C. (2021) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-3293-x · Cited by 15
Transcriptomic Analysis of Hepatic Cells in Multicellular Organotypic Liver Models
Tegge, A. N., Rodrigues, R. R., Larkin, A. L., Vu, L. T., Murali, T. M., & Rajagopalan, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-29455-x · Cited by 15
Angiocrine Signaling in Sinusoidal Health and Disease
Cooper, S. A., Kostallari, E., & Shah, V. H. (2023) · Seminars in Liver Disease · doi:10.1055/a-2128-5907 · Cited by 15
The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies
Mo, H., Yue, P., Li, Q., Tan, Y., Yan, X., Liu, X., Xu, Y., Luo, Y., Palihati, S., Yi, C., et al. (2025) · Angiogenesis · doi:10.1007/s10456-025-09969-5 · Cited by 15
“These findings suggest that capillarization may be a necessary step in the development of fibrosis [23, 51, 124].”
Hepatobiliary organoids differentiated from hiPSCs relieve cholestasis-induced liver fibrosis in nonhuman primates
Li, H., Li, J., Wang, T., Sun, K., Huang, G., Cao, Y., Wu, F., & Xu, A. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90441 · Cited by 15
“The most remarkable phenotypic change of hepatic sinusoid capillarization is the loss of fenestrae, also called defenestration, associated with the formation of a basement membrane on the abluminal surface of LSECs, which is the prelude to fibrosis [33, 34] .”
Background
Phloridzin Reveals New Treatment Strategies for Liver Fibrosis
Shi, Y., Yan, T., Lu, X., Li, K., Nie, Y., Jiao, C., Sun, H., Li, T., Li, X., & Han, D. C. (2022) · Pharmaceuticals · doi:10.3390/ph15070896 · Cited by 14
“In addition, there are also studies on the causes of liver fibrosis, including damage to hepatocytes [6], fenestrae decrease in liver sinusoidal endothelial cells [7], and activation of liver Kupffer cells [8].”
Background
Engineered matrix microenvironments reveal the heterogeneity of liver sinusoidal endothelial cell phenotypic responses
Brougham‐Cook, A., Kimmel, H., Monckton, C. P., Owen, D., Khetani, S. R., & Underhill, G. H. (2022) · APL Bioengineering · doi:10.1063/5.0097602 · Cited by 15
Tissue-resident memory CD8+ T cells: master deciphers of the hepatic environment
Romero, D. B., Finney, G. E., Dudek, M., & Pallett, L. J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01118-z · Cited by 13
“Critically, these sinusoidal fenestrations are progressively lost during LSEC capillarization in fibrosis 111,112 .”
Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing
Liu, T., Ge, Y., Chen, Z., Wu, L., Tian, T., Yao, W., & Zhao, J. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00213 · Cited by 13
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Harini, K. S., & Ezhilarasan, D. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105467 · Cited by 14
Single-Cell RNA Sequencing Reveals the Spatial Heterogeneity and Functional Alteration of Endothelial Cells in Chronic Hepatitis B Infection
Shi, J., Li, Q., Li, J., Zhou, J., Zhang, X., Wang, S., & Guo, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137016 · Cited by 14
Hepatic stellate cells in zone 1 engage in capillarization rather than myofibroblast formation in murine liver fibrosis
Khan, M. A., Fischer, J., Harrer, L., Schwiering, F., Groneberg, D., & Friebe, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-69898-z · Cited by 13
“( c ) tdTomato-expressing myofibroblasts were also not detected after the short CCl 4 protocol. and synthesis of a basement membrane 20,21 .”
Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis
Petrillo, S., Manco, M., Altruda, F., Fagoonee, S., & Tolosano, E. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8168 · Cited by 13
Hypoxia maintains the fenestration of liver sinusoidal endothelial cells and promotes their proliferation through the SENP1/HIF-1α/VEGF signaling axis
Qing, Z., Huang, H., Yang, S., Lin, J., Zeng, Z., Duan, J., Yuan, B., & Ming, T. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.104 · Cited by 13
Dietary alcohol exacerbates the hepatotoxicity induced by pyrrolizidine alkaloids: Hazard from food contamination
He, Y., Long, Y., Zhang, C., Ma, J., Ke, C., Tang, C., Ye, Y., & Lin, G. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127706 · Cited by 13
Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches
Rajapaksha, I. G. (2022) · Livers · doi:10.3390/livers2040028 · Cited by 14
Generation & characterization of expandable human liver sinusoidal endothelial cells and their application to assess hepatotoxicity in an advanced in vitro liver model
Kaden, T., Noerenberg, A., Boldt, J., Sagawe, C., Johannssen, T., Rennert, K., Raasch, M., & Evenburg, T. (2022) · Toxicology · doi:10.1016/j.tox.2022.153374 · Cited by 13
The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study
Zeng, D., Liang, D., Zhang, R.-C., Guo, Q., Duan, B., Jia, C., Chen, F., Lin, D., Zang, Y., & Lu, S. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/5459427 · Cited by 12
“The elevated serum HA level in the cirrhosis patient is due to the fact that the liver sinusoidal endothelial cells reduce the uptake of HA [31].”
Background
Autoimmune Hepatitis and Stellate Cells: An Insight into the Role of Autophagy
Golbabapour, S., Lankarani, K. B., Ghavami, S., & Geramizadeh, B. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190402120231 · Cited by 13
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Buniatian, G. H., Weiskirchen, R., Weiß, T. S., Schwinghammer, U., Fritz, M., Seferyan, T., Proksch, B., Glaser, M., Lourhmati, A., Buadze, M., et al. (2020) · Cells · doi:10.3390/cells9020452 · Cited by 13
Anatomy and Cellular Functions of the Liver
Qin, L., & Crawford, J. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00001-x · Cited by 17
The Liver Sinusoidal Endothelial Cell
Sørensen, K. K., & Smedsrød, B. H. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch34 · Cited by 13
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis
Wang, L., Huang, Y., Chen, J., Gao, J., Chen, S., Zhao, M., Lin, J., Zhou, S., Shen, Y., & Cheng, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1635763 · Cited by 15
“During fibrosis, VEGF derived from hepatocytes and HSCs maintains the fenestration phenotype of LSECs through the eNOS-sGC pathway and non-NO-dependent pathways (DeLeve, 2015).”
Soluble Guanylyl Cyclase Activator BI 685509 Reduces Portal Hypertension and Portosystemic Shunting in a Rat Thioacetamide-Induced Cirrhosis Model
Jones, A. K., Chen, H., Ng, K. J., Villalona, J., McHugh, M., Zeveleva, S., Wilks, J., Brilisauer, K., Bretschneider, T., Qian, H. S., et al. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001532 · Cited by 14
“…in NO also cause capillarization of liver sinusoidal endothelial cells (LSECs), which may further promote activation of HSCs (Xie et al., 2012; DeLeve, 2015), enabling the constriction of portal blood ﬂ ow and tissue remodeling that lead to portal hypertension and liver ﬁ brosis (Thimgan and…”
Background
Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis
Tan, P. K., Ostertag, T. M., Rosenthal, S. B., Chilin-Fuentes, D., Aidnik, H., Linker, S. B., Murphy, K., Miner, J. N., & Brenner, D. A. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.12.005 · Cited by 12
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis
Chen, S., Zhuang, D., Jia, Q., Guo, B., & Hu, G. (2024) · Biomaterials Research · doi:10.34133/bmr.0042 · Cited by 14
“Importantly, capillarization is an early event that precedes the onset of liver fibrosis [53,54] and maybe a permissive condition for the development of fibrosis [55,56].”
Background
Influence of microflow on hepatic sinusoid blood flow and red blood cell deformation
Wang, T., Lü, S., Hao, Y., Su, Z., Long, M., & Cui, Y. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.09.020 · Cited by 12
Liver Fibrosis Assessment by Viewing Sinusoidal Capillarization: US Molecular Imaging versus Two-dimensional Shear-Wave Elastography in Rats
Miao, X., Sha, T., Zhang, W., Zhou, H., Qiu, C., Deng, H., You, Y., Ren, J., Zhang, X., Zheng, R., et al. (2022) · Radiology · doi:10.1148/radiol.212325 · Cited by 12
Effect of Curcumol on the Fenestrae of Liver Sinusoidal Endothelial Cells Based on NF‐κB Signaling Pathway
Zheng, Y., Wang, J., Wang, J., Xie, H.-Y., & Zhao, T. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8590638 · Cited by 12
“0is lesion can activate hepatic stellate cells, leading to liver fibrosis [29].”
Background
Role of Oxidative and Nitrosative Stress in Hepatic Fibrosis
le, T. T. T., Thuy, T. T. V., Hai, H., & Kawada, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00016-3 · Cited by 13
Adult hepatocytes direct liver organogenesis through non-parenchymal cell recruitment in the kidney
Utoh, R., Komori, J., Kuge, H., Tatsumi, K., Yamada, M., Hirohashi, S., Tsutsumi, M., Amanuma, T., Yoshioka, A., Nakajima, Y., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.016 · Cited by 12
Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer
Sererols-Viñas, L., Garcia‐Vicién, G., Ruiz-Blázquez, P., Lee, T., Lee, Y. A., Gonzalez‐Sanchez, E., Vaquero, J., Moles, A., Filliol, A. A., & Affò, S. (2025) · Seminars in Liver Disease · doi:10.1055/a-2551-0724 · Cited by 16
Targeting Polymeric Nanoparticles to Specific Cell Populations in the Liver
Harkins, L., Vilarinho, S., & Saltzman, W. M. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00712 · Cited by 11
YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling
Wang, J., Shen, Z., Chen, G., Dai, W., Mei, Z., Shen, B., Guo, Y., Wang, J., Zhangdi, H., Zhang, Q., et al. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00798-4 · Cited by 12
Suppressed Histone H3 Lysine 18 Acetylation Is Involved in Arsenic-Induced Liver Fibrosis in Rats by Triggering the Dedifferentiation of Liver Sinusoidal Endothelial Cells
Hu, F., Zhou, X., Peng, Q., & Ma, L. (2023) · Toxics · doi:10.3390/toxics11110928 · Cited by 11
“…involvement of dedi ﬀ erentiation of LSECs in arsenic-induced hepatic stellate cell activation and liver ﬁ brosis. observed to signi ﬁ cantly correlate with elevated levels of α -SMA (Figure 3C) and ECM (Figure S3B) and is associated with collagen deposition and the content of Col Ⅰ (Figure 3D,E).”
Background
Coculture model of a liver sinusoidal endothelial cell barrier and HepG2/C3a spheroids-on-chip in an advanced fluidic platform
Messelmani, T., Goff, A. L., Soncin, F., Souguir, Z., Merlier, F., Maubon, N., Legallais, C., Leclerc, É., & Jellali, R. (2023) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2023.10.006 · Cited by 13
Chronic heart failure induces early defenestration of liver sinusoidal endothelial cells ( LSECs ) in mice
Wojnar‐Lason, K., Tyrankiewicz, U., Kij, A., Kurpińska, A., Kaczara, P., Kwiatkowski, G., Wilkosz, N., Giergiel, M., Stojak, M., Grosicki, M., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14114 · Cited by 11
“16,17 Dysfunctional LSECs may display pro-inflammatory phenotype, 16,18 altered production of LSEC-derived vasodilators and vasoconstrictors (e.g., NO, thromboxane A2, prostaglandins) 10,19 reduced endocytic capacity, changes in LSECs bioenergetics and other alterations in LSECs phenotype.”
Background
Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosis
Liu, Y., & Wang, L. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100040 · Cited by 11
IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25+Foxp3- T cells
Tomala, J., Weberova, P., Tomalová, B., Zakostelska, Z. J., Sivák, L., Kovářová, J., & Kovář, M. (2021) · eLife · doi:10.7554/elife.62432 · Cited by 10
Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis
Lee, K. S., Santagostino, S. F., Li, D., Ramjit, A. L., Serrano, K., Ginsberg, M. D., Ding, B., Rafii, S., & Madoff, D. C. (2017) · Radiology · doi:10.1148/radiol.2017162617 · Cited by 12
CTRP13 attenuates the expression of LN and CAV-1 Induced by high glucose via CaMKKβ/AMPK pathway in rLSECs
Zhang, Q., Niu, X., Tian, L., Liu, J., Niu, R., Quan, J., Yu, J., Lin, W., Qian, Z., & Zeng, P. (2020) · Aging · doi:10.18632/aging.103234 · Cited by 11
“basement membrane and defenestration of LSECs [28, 29].”
New insights into combined immunotherapy for hepatocellular carcinoma associated with liver cirrhosis
Liu, Y., Cong, K., Li, Q., Zhang, D., & Sheng, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1741398 · Cited by 12

Authors: DeLeve, L. D.
Affiliations: University of Southern California (US)
Corresponding author: DeLeve, Laurie D.
ORCID: DeLeve, Laurie D.
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2015-03-23
Volume: 61
Issue: 5
Pages: 1740-1746
ISSN: 0270-9139 (ISSN-L)
1527-3350
DOI: 10.1002/hep.27376
PMC: PMC4333127
OpenAlex: W1781806439
Cited by: 482
References: 50
Citations by year: 2026: 45 · 2025: 44 · 2024: 60 · 2023: 40 · 2022: 39 · 2021: 51 · 2020: 49 · 2019: 37 · 2018: 46 · 2017: 35 · 2016: 26 · 2015: 9
FWCI: 3.08
Type: journal article
Language: en
Update notices: correction (2015-07-01)
Open access: green
www.ncbi.nlm.nih.gov
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 162 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100580, DK-66423, R01DK066423)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: liver sinusoidal endothelial cells, liver fibrosis, capillarization, endothelial fenestrations, basement membrane formation, hepatic stellate cell activation, VEGF signaling, nitric oxide, HSC quiescence, fibrosis regression, liver cirrhosis
MeSH terms: Cell Differentiation, Humans, Liver Cirrhosis, Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liver sinusoidal endothelial cells in hepatic fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks